Synthesis of the protein phosphatase 2A inhibitor (4S,5S,6S,10S,11S,12S)-cytostatin.

[1]  H. Waldmann,et al.  Natural products are biologically validated starting points in structural space for compound library development: solid-phase synthesis of dysidiolide-derived phosphatase inhibitors. , 2002, Angewandte Chemie.

[2]  O. Müller,et al.  Naturstoffe sind biologisch validierte Startpunkte im Strukturraum zur Entwicklung von Substanzbibliotheken: Festphasensynthese von Analoga des Protein-Phosphatase-Inhibitors Dysidiolid , 2002 .

[3]  P. Wipf,et al.  Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25. , 2001, Journal of medicinal chemistry.

[4]  E. Jacobsen,et al.  Total Synthesis of Fostriecin (CI‐920) , 2001 .

[5]  Z. Zhang,et al.  Protein tyrosine phosphatases: prospects for therapeutics. , 2001, Current opinion in chemical biology.

[6]  A. Bridges,et al.  Chemical inhibitors of protein kinases. , 2001, Chemical reviews.

[7]  S. Suchard,et al.  Potent reversible inhibitors of the protein tyrosine phosphatase CD45. , 2001, Journal of medicinal chemistry.

[8]  D. Boger,et al.  Total synthesis of fostriecin (CI-920). , 2001, Journal of the American Chemical Society.

[9]  A. Lee,et al.  A simple and highly efficient deprotecting method for methoxymethyl and methoxyethoxymethyl ethers and methoxyethoxymethyl esters , 2001 .

[10]  R. Shirai,et al.  Synthesis of the novel analogues of dysidiolide and their structure-activity relationship. , 2000, Bioorganic & medicinal chemistry letters.

[11]  T. Hunter,et al.  Signaling—2000 and Beyond , 2000, Cell.

[12]  T Takeuchi,et al.  Cytostatin, an inhibitor of cell adhesion to extracellular matrix, selectively inhibits protein phosphatase 2A. , 1999, Biochimica et biophysica acta.

[13]  J. Rudolph,et al.  Dysidiolide and related gamma-hydroxy butenolide compounds as inhibitors of the protein tyrosine phosphatase, CDC25. , 1999, Bioorganic & medicinal chemistry letters.

[14]  M. Kawada,et al.  Differential Induction of Apoptosis in B16 Melanoma and EL‐4 Lymphoma Cells by Cytostatin and Bactobolin , 1999, Japanese journal of cancer research : Gann.

[15]  H. Waldmann,et al.  Organische Synthese und biologische Signaltransduktion , 1998 .

[16]  Tomoko Nakamura,et al.  Protection of phosphate with the 9-fluorenylmethyl group. Synthesis of unsaturated-acyl phosphatidylinositol 4,5-bisphosphate , 1997 .

[17]  T. Ikariya,et al.  Asymmetric Transfer Hydrogenation of a,-Acetylenic Ketones , 1997 .

[18]  C. Gauss,et al.  Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins. , 1997, Bioorganic & medicinal chemistry.

[19]  D. Boger,et al.  Determination of the Relative and Absolute Stereochemistry of Fostriecin (CI-920) , 1997 .

[20]  J. Vilarrasa,et al.  Highly Enantioenriched Propargylic Alcohols by Oxazaborolidine-Mediated Reduction of Acetylenic Ketones. , 1996, The Journal of organic chemistry.

[21]  K. A. Parker,et al.  Asymmetric Reduction. A Convenient Method for the Reduction of Alkynyl Ketones. , 1996, The Journal of organic chemistry.

[22]  H. Haruyama,et al.  Absolute configuration of leustroducsins , 1995 .

[23]  T. Takeuchi,et al.  Inhibitory effect of cytostatin on spontaneous lung metastases of B16-BL6 melanoma cells. , 1995, The Journal of antibiotics.

[24]  T. Takeuchi,et al.  Cytostatin, a novel inhibitor of cell adhesion to components of extracellular matrix produced by Streptomyces sp. MJ654-NF4. I. Taxonomy, fermentation, isolation and biological activities. , 1994, The Journal of antibiotics.

[25]  H. Naganawa,et al.  Cytostatin, a novel inhibitor of cell adhesion to components of extracellular matrix produced by Streptomyces sp. MJ654-NF4. II. Physico-chemical properties and structure determination. , 1994, The Journal of antibiotics.

[26]  T. Kinoshita,et al.  Novel microbial metabolites of the phoslactomycins family induce production of colony-stimulating factors by bone marrow stromal cells. II. Isolation, physico-chemical properties and structure determination. , 1993, The Journal of antibiotics.

[27]  P. Ramachandran,et al.  Chiral synthesis via organoboranes. 34. Selective reductions. 47. Asymmetric reduction of hindered .alpha.,.beta.-acetylenic ketones with B-chlorodiisopinocampheylborane to propargylic alcohols of very high enantiomeric excess. Improved workup procedure for the isolation of product alcohols , 1992 .

[28]  D. Dess,et al.  A useful 12-I-5 triacetoxyperiodinane (the Dess-Martin periodinane) for the selective oxidation of primary or secondary alcohols and a variety of related 12-I-5 species , 1991 .

[29]  A. Alexakis,et al.  Expeditious synthesis of the four isomers of methyl dimorphecolate , 1991 .

[30]  Joel Morris,et al.  The total synthesis of the polyether antibiotic X-206 , 1988 .

[31]  E. Corey,et al.  Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. Mechanism and synthetic implications , 1987 .

[32]  J. Stille,et al.  Stereospecific cross-coupling of vinyl halides with vinyl tin reagents catalyzed by palladium , 1987 .

[33]  J. C. French,et al.  Novel antitumor agents CI-920, PD 113 270, and PD 113 271. 3. Structure determination , 1985 .

[34]  D. Evans,et al.  Enantioselective aldol condensations. 2. Erythro-selective chiral aldol condensations via boron enolates , 1981 .

[35]  J. Miyashiro,et al.  Improved Procedure for the Reduction of N-Acyloxazolidinones , 1990 .

[36]  W. C. Still,et al.  Direct synthesis of Z-unsaturated esters. A useful modification of the horner-emmons olefination. , 1983 .

[37]  R. Hatch,et al.  Reduction of .alpha.,.beta.-acetylenic ketones with B-3-pinanyl-9-borabicyclo[3.3.1]nonane. High asymmetric induction in aliphatic systems , 1980 .